Fosun taps big buyout funds for Gland Pharma

Chinese billionaire Guo Guangchang’s Shanghai Fosun Pharmaceutical Group is the controlling shareholder of listed generic injectables maker Gland, with 57.86% stake. The buyout will trigger an open offer for an additional 26% of the company.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/0qsAJih
via IFTTT